Streetbeat News

MRX

Marex Group Plc

https://www.marex.com/

Open

30.64

Mkt cap

2.2B

Volume

263K

High

31.14

P/E Ratio

12.30

52-wk high

32.45

Low

30.32

Div yield

0.01

52-wk low

18.13

PCB, ZION, and MRX have been listed as Zacks Rank #1 (Strong Buy) income stocks for December 3, 2024, indicating strong potential for income-focused investors.

Portfolio Pulse from

December 03, 2024 | 10:15 am

MRX, PCB, and ZION have been identified as top value stocks by Zacks, achieving a Rank #1 (Strong Buy) for December 3, 2024.

Portfolio Pulse from

December 03, 2024 | 10:00 am

Marex Group PLC (MRX) has been upgraded to a Zacks Rank #1 (Strong Buy), indicating growing optimism about its earnings prospects.

Portfolio Pulse from

November 26, 2024 | 6:15 pm

WASH, MRX, and ZIM have been listed as Zacks Rank #1 (Strong Buy) income stocks for November 26, 2024.

Portfolio Pulse from

November 26, 2024 | 9:30 am

Marex Group plc (Nasdaq: MRX) reported strong financial results for Q3 2024, with significant increases in revenue, profit before tax, and earnings per share compared to the previous year. The company also upgraded its outlook for the full year.

Portfolio Pulse from

November 07, 2024 | 12:15 pm

Marex Group has announced the pricing of its public offering of 8,472,333 shares at $24.00 per share.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 1:04 pm

Marex Group has announced a public offering of 7 million ordinary shares by certain selling shareholders. Additionally, the underwriters have a 30-day option to purchase up to an additional 1.05 million shares.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:54 pm

Marex Group has agreed to acquire Hamilton Court Group, a company offering a range of FX products. The terms of the acquisition have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 11:11 am

Marex Group (NASDAQ:MRX) has been analyzed by four analysts, showing a somewhat bullish sentiment with an average 12-month price target of $28.75, up from $26.75. Analysts from Barclays and Piper Sandler have raised their price targets, indicating positive expectations. Despite this, Marex Group faces challenges with below-average net margins and high debt-to-equity ratios.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 7:00 pm

Barclays analyst Benjamin Budish maintains an Overweight rating on Marex Group (NASDAQ:MRX) and raises the price target from $28 to $30.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 6:56 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.